Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

SRUC seeking dairy farmers for M. bovis study
M. bovis is unique in that it has no cell wall, and so common antibiotics such as penicillin don't work against it.

Findings will help in developing schemes to limit spread

Scientists from Scotland’s Rural College (SRUC) are urging dairy farmers across the country to participate in a new study, with the aim of gaining a better understanding of the spread of Mycoplasma bovis in cattle.

Mycoplasma bovis (M. bovis) can cause several diseases in cows, including bovine respiratory disease (BRD); pneumonia; middle ear disease, resulting in a head tilt; mastitis and arthritis.

In an effort to gather more knowledge on the distribution of M. bovis in Scotland, as well an understanding of how it spreads within and between farms, the SRUC Veterinary Services team is seeking Scottish dairy farms to take part in a new year-long study.

According to SRUC, the study will consist of bulk tank milk sampling and a short questionnaire on general herd management. Farms taking part in the study will receive their own results throughout the year from their registered veterinary practice.

Project lead Jessica Ireland-Hughes, from SRUC Veterinary Services, said: “This project will be of huge benefit to the industry as we currently don’t know how many farms have ongoing M. bovis-associated disease and which farms are more or less at risk.

“There is currently no national control scheme in place for this disease, and the results of this project will help develop more structured control plans to limit spread between and within herds, help manage the welfare and economic effects and reduce the reliance on antimicrobials.”

The Scottish Dairy Hub will be sending a flyer containing more information to all Scottish dairy farmers in the next week. Those wishing to participate can also email mycoplasmabovis@sruc.ac.uk.

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.